Defendants shall be punished by fine for negligence of KRW 30,000,000.

Defendant

If A does not pay the above fine, 100,000 won.

Punishment of the crime

1. Defendant A is a person in charge of the external supply, sale, advertisement, etc. of food additives sold in (State)B while serving as a managing director in the location of 401 (main director E) of Gangnam-gu Seoul Metropolitan D Building as a managing director.

No one shall put a mark on a container, package or appended document that is likely to mislead people into misunderstanding that articles other than drugs have medical efficacy, efficacy, etc., or advertise such contents, and shall sell an article indicated or advertised similar to those of drugs, store or display such articles for sale.

Nevertheless, from January 2, 2013 to November 30, 2017, the Defendant sold the above “F” disinfection agents at the above place from around November 2, 2017. The Defendant, despite that the disinfection agents are food additives and are not medicine, posted a Stick printed on the product container, such as “flaping various car theme, operating apparatus, anesthesia, etc.”, and attaching f4 liters to Byung, National Assembly members, etc., as indicated in the list of crimes attached to the above period.

62,669 total sum of 485,748,420 won was sold.

As a result, the defendant put a mark on the container, package or appended document that is not a drug that is likely to be mistaken for medical efficacy, effect, etc., and sold it.

2. Defendant B, a juristic person established for the purpose of manufacturing and selling medicines, etc., and the above Defendant A, a representative of the Defendant, placed a mark on the container, package or appended document, which is likely to mislead the Defendant into being of medical efficacy, effect, etc. with respect to non-pharmaceuticals, at the above period and place, and sold them.

Summary of Evidence

1. Defendants’ respective legal statements

1. A protocol concerning the examination of each police officer in relation to G;

1. Reporting on the F4L purchase ledger, F4L sales details, and F sales details;

1. The Act applies 1.5% of each one of the 16-year production Frax, “17-year production Frax,” respectively.